← Back to home

Lilly's Experimental Drug Tops Ozempic for Weight Loss in Trial

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

People with Type 2 diabetes who took Eli Lilly's experimental drug retatrutide lost about twice as much weight as those on Ozempic, Lilly said…

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

2 sources behind this story.

About this story

We haven’t published a correction to this story.

How NewsPlain works
← Back to home
Lilly's Experimental Drug Tops Ozempic for Weight Loss in Trial — NewsPlain